Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
about
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsImaging the serotonin transporter during major depressive disorder and antidepressant treatmentHow the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging studySerotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholicsCompartmental modeling of 11C-HOMADAM binding to the serotonin transporter in the healthy human brain.Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingIn vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomographySustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.Architectonic distribution of the serotonin transporter within the orbitofrontal cortex of the vervet monkeyDifferences between males and females in rates of serotonin synthesis in human brain.PET and SPECT imaging in psychiatric disorders.Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex.Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan.Binding potency of paroxetine analogues for the 5-hydroxytryptamine uptake complex.Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration.Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.Test-retest reliability of the SERT imaging agent [(11)C]HOMADAM in healthy humans.Unaltered number of brain serotonin uptake sites in suicide victims.Serotonin transporter binding is reduced in seasonal affective disorder following light therapy.Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?Paroxetine-induced dysarthria in a 42-year-old man with pathologic laughing.Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
P2860
Q24677228-05930635-E80E-40FC-BE6A-285E6E833A2BQ24683135-433373F3-33A8-42C5-A30C-C902C064EDDAQ30485725-48B91A74-E2D9-46BC-819A-3161DC24C687Q32052220-FAC44472-FB9E-41BB-B5D9-9FB4D9EC2198Q34073200-1239E374-12E5-4DC9-B484-85CFFA0F6DFCQ34447503-3DD5F585-1A83-46A5-81CA-595607010676Q34660724-249C2A62-75E8-452D-A0C6-38439D13AB7AQ34727498-81C4ACD7-8530-4675-891E-C59F4F62EE1DQ34795520-3ED92FA2-3038-4A3C-8556-17B1AAE3C419Q35580506-6E20E3EA-E350-4CCC-827C-40D46E7566B7Q35687937-97AD31E0-66FC-4F68-92D8-21A0825989B5Q35878500-CAD08C0E-3EC0-4BF8-B120-6B8C08F01B46Q35892741-93B66622-9161-44A8-A6F0-1B2641CA4CEAQ36082764-7D168236-7505-469D-BE05-7C4776E65AB1Q36131232-D53F0660-23AA-429F-88B7-F0C5A0BF7896Q36772213-8E9B91C1-EEFC-4406-B3DC-BEF8067C3D91Q36811276-4EAD83AD-75E3-48F1-8221-E8C42E168C1BQ37088446-6B108F8E-836F-4BE8-AD15-95D3FEF404F4Q37261294-EEC34BFD-C12A-475B-B771-B69417C474C2Q37365633-5C177668-FFA8-4239-9EC6-59ECC99DA9C3Q40874556-AD1041D4-EE4C-477F-BB7A-68A9C6DA5605Q41107442-36EE96B3-C9DE-4CF6-BF6F-33C3F40FA46BQ42436209-18BC938D-8941-4A44-841C-B855CA48FCD7Q43700709-F4CAEC24-C34A-48AE-AF49-7A62B6FEA2F2Q43794820-710F6771-AF9D-4E2D-AA93-E794ED6801F4Q44153719-B2547DCC-CEE1-444F-BBF6-0653CCFE9428Q44317390-53B1B1D4-747E-48F4-813E-247B0C4E5AB4Q44359164-C9857F5C-603B-4A9D-8227-ED17B7E97BD3Q44897778-40B09BD9-3A18-4E86-A680-C038AB736E46Q45729007-AD2B7124-CF47-4199-ACA1-6F093A424A77Q46936349-75573C85-39ED-4E0E-AF2F-840219A6D0D0Q47350100-A4D11765-1E90-4B6C-BD61-45434718AE8FQ47568558-7143CD19-F1FD-4075-960F-1FA875BE3721Q47746015-C4A26831-453E-4671-842E-1908FD12CDADQ47954755-D9EE04E7-A005-4A42-94A4-E7BD2B7AD97AQ48375763-623169B6-9105-4161-BFB0-3DAAFF8CCEB6Q50606896-D3A965CA-9469-4D69-898D-898C476C5758Q51804384-A5B68E2A-58F8-45A6-83D3-21BDAA04B634
P2860
Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Regional and subcellular local ...... ker of serotonin uptake sites.
@en
Regional and subcellular local ...... ker of serotonin uptake sites.
@nl
type
label
Regional and subcellular local ...... ker of serotonin uptake sites.
@en
Regional and subcellular local ...... ker of serotonin uptake sites.
@nl
prefLabel
Regional and subcellular local ...... ker of serotonin uptake sites.
@en
Regional and subcellular local ...... ker of serotonin uptake sites.
@nl
P2093
P1476
Regional and subcellular local ...... ker of serotonin uptake sites.
@en
P2093
Laruelle M
Maloteaux JM
Vanisberg MA
P304
P356
10.1016/0006-3223(88)90198-9
P407
P577
1988-07-01T00:00:00Z